Prime Medicine, Inc.
PRME·33739Q606·UN·ETF·Healthcare - Biotechnology
PRME (Prime Medicine, Inc.) is held by 0 institutional investors as of Q3 2019. Net institutional sentiment: Bearish.
0
Holders
$0
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Aug 5, 2025 · Activists none · Congress none
InsiderNRNELSEN ROBERTBuy $10.0MAug 1, 2025
InsiderGLGV 2021 GP, L.L.C.Buy $5.0MAug 1, 2025
InsiderALARCH Venture Partners X, LLCBuy $10.0MAug 1, 2025
Checking access…
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $352,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $227,000 | 0.0% | — | 0 |
PRMEPrime Medicine, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUNITEDHEALTH GROUP INC417 holders · $300.5B
LLYELI LILLY & CO416 holders · $881.6B
TMOTHERMO FISHER SCIENTIFIC INC401 holders · $151.5B
JNJJOHNSON & JOHNSON398 holders · $415.6B
DHRDANAHER CORP DEL395 holders · $98.9B
ISRGINTUITIVE SURGICAL INC394 holders · $111.8B
MRKMERCK & CO INC391 holders · $230.3B
ABBVABBVIE INC386 holders · $303.9B
BSXBOSTON SCIENTIFIC CORP386 holders · $52.4B
ABTABBOTT LABORATORIES383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer